View today's Taisho Pharmaceutical Hold Ltd stock price and latest 4581 news and analysis. Create real-time notifications to follow any changes in the live stock price.

View real-time Taisho Pharmaceutical Hold Ltd (4581) live share price and historical data, charts, technical analysis, financial reports and other TYO:4581 stock data today.

The Energy Drinks Market was valued at USD 79.39 billion in 2024, and is projected to reach USD 125.11 billion by 2030, rising at a CAGR of 8%. The demand for these drinks has been driven by ...

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. is a holding company engaged in the self-medication business and medical business. The Self-Medication segment ...

Buyout Price: In March, Oasis said it was considering legal action over Taisho's $5 billion management buyout - Japan's largest to date - arguing that it was deeply unfair to minority shareholders.

Review quarterly and annual revenue, net income, and cash flow for Taisho Pharmaceutical Holdings Co Ltd ADR (TAIPY:PINX) stock through the last fiscal year.

Get Taisho Pharmaceutical Ind historical price data for SQBI_p stock. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change.

Short interest for Taisho Pharmaceutical gives investors a sense of the degree to which investors are betting on the decline of Taisho Pharmaceutical's stock. Short interest data is updated every ...

CHICAGO-- (BUSINESS WIRE)--Curi RMB Capital opposes the management buyout (“the MBO”) of Taisho Pharmaceutical Holdings Co., Ltd. (4581 JP, TSE Standard, “Taisho”) because we believe the MBO is unfair ...

Oasis Management, a Hong Kong-based activist fund, said it is opposed to Taisho Pharmaceutical's $5 billion management buyout as it believes the acquisition price was too low.

Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, science, ...

TOKYO -- Taisho Pharmaceutical Holdings will be delisted following the successful completion of a tender offer from a company owned by a member of the founding family, the drugmaker announced Tuesday.